topright menu
EANO LOGO

Neurosurgery

Correlation between clinical features, magnetic resonance imaging, and histopathologic findings in retinoblastoma: a prospective study.

Go to article on Pubmed
 

Radiotherapy

Clinical Trials

Use of (11)C-methionine PET parametric response map for monitoring WT1 immunotherapy response in recurrent malignant glioma.

Go to article on Pubmed
 

Brain Metastases

Brain metastases as the primary site of relapse in two randomized phase III pemetrexed trials in advanced non-small-cell lung cancer.

Go to article on Pubmed
 

Patient Care

Basic science

The glucocorticoid receptor and its expression in the anterior pituitary and the adrenal cortex: a source of variation in hypothalamic-pituitary-adrenal axis function; implications for pituitary and adrenal tumors.

Go to article on Pubmed
 

Complete resolution of advanced Mycoplasma pneumoniae encephalitis mimicking brain mass lesions: report of two pediatric cases and review of literature.

Go to article on Pubmed
 
Member Login
Email
Password
Forgot your password?
Become a member

The EANO website serves the neurooncology community by providing current research news on neurooncology topics, facilitating collaboration on research projects, advertising job opportunities, providing a discussion forum for members and disseminating information about relevant events.

EANO members can login to access the full website. If you're not a member, find out here how to become an EANO member.


Oligodendroglioma-like component in GBM not associated with better outcome
Departments of Pathology, Radboud University Nijmegen Medical Center, Nijmegen, and VU University Medical Center, Amsterdam, the Netherlands

Dr. Pieter Wesseling was a co-author of a study recently published in Acta Neuropathologica. The paper described the finding that in a series of 339 high grade gliomas originally diagnosed as glioblastoma (GBM), 15% were identified as having an oligodendroglioma-like component (GBM-O). However, in this series GBM-O was not associated...


Vinblastine as an alternative to RT in paediatric LGG
Interview with Eric Bouffet, MD, by our journalist Stuart Bell
Director, Brain Tumour Program,
The Hospital for Sick Children, Toronto, Canada.

Dr. Eric Bouffet was first author of a paper recently published in the Journal of Clinical Oncology. The paper described a phase II study of weekly vinblastine in recurrent/refractory paediatric low-grade glioma. Weekly vinblastine administered for 1 year resulted in 36% of patients showing complete, partial or minor response. At median follow-up of 67 months 45% of patients had not experienced progression. Five-year OS was 93.2% ....


Early registration for the 10th EANO meeting in Marseille before June 15

The reduced registration fee is only applicable, if it has been credited to the congress account before the deadline. Registering before the respective deadlines without performing an actual payment is not sufficient to benefit from the reduction.


Call for applications for the EANO Executive Board
Dear EANO members,

We invite you to apply for upcoming open positions for the EANO Executive board. The EANO board is the steering body of EANO, and has the responsibility for the society. The board is composed of representatives of different specialities and each member has specific tasks and competencies. The available positions and their function in the board are shown on the table. .....


Call for applications for the EANO Scientific Board
Dear colleagues,

The Executive Board of EANO has implemented a new Scientific Committee for EANO 2012. This committee was built from the former members of scientific advisors for previous EANO conferences and new members that have been chosen from your applications in September 2011.....


EACR 22th pre-congress symposium on brain cancer, 7 July 2012 Barcelona

Prior to the start of the EACR Congress on Saturday afternoon, the Seve Ballesteros  Foundationwill hold itsthird Symposium on Brain Cancer for interested participants. It is widely accepted that it is no longer enough for cancer researchers to debate and exchange among themselves...

Contact us Search Home

REPORT FROM NATIONAL SOCIETIES JOINT MEETING AINO (Italian Association for Neuro-Oncology) / ANOCEF (Association des Neuro-Oncologues d’Expression Française)
European Association of Neurooncology